Insulin resistance in idiopathic dilated cardiomyopathy - A possible etiologic link

被引:95
作者
Witteles, RM
Tang, WHW
Jamali, AH
Chu, JW
Reaven, GM
Fowler, MB
机构
[1] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA
[2] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[3] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA
[4] Stanford Univ, Sch Med, Div Endocrinol & Metab, Stanford, CA 94305 USA
关键词
D O I
10.1016/j.jacc.2004.03.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study was designed to quantify the prevalence of abnormal glucose tolerance and insulin resistance in patients with idiopathic dilated cardiomyopathy (IDCM). BACKGROUND Insulin resistance is an independent risk factor for mortality in patients with heart failure (HF) and is a known risk factor for ischemic cardiomyopathy. Though potential physiologic links between insulin resistance and HF have been hypothesized, the relationship between insulin resistance and IDCM remains unclear. METHODS A total of 230 consecutive patients from a university HF clinic were screened for IDCM, the absence of diabetes mellitus, and the lack of significant co-morbid conditions. Oral glucose tolerance tests were performed in the 43 patients with IDCM who met these criteria, and their plasma glucose and insulin responses were compared with those of 40 healthy volunteers, matched for age, gender, and body mass index. RESULTS Plasma glucose responses were higher during the oral glucose tolerance tests in patients with IDCM (p < 0.01), associated with significantly higher plasma insulin concentrations following the oral glucose challenge (p < 0.01). In addition, abnormalities of glucose tolerance were significantly (p < 0.05) more common in patients with IDCM (49% vs. 23%). CONCLUSIONS Insulin resistance and abnormal glucose tolerance are more prevalent in patients with IDCM and represent potentially reversible metabolic derangements in these individuals. (C) 2004 by the American College of Cardiology Foundation.
引用
收藏
页码:78 / 81
页数:4
相关论文
共 29 条
  • [1] INSULIN THERAPY IN OBESE, NON-INSULIN-DEPENDENT DIABETES INDUCES IMPROVEMENTS IN INSULIN ACTION AND SECRETION THAT ARE MAINTAINED FOR 2 WEEKS AFTER INSULIN WITHDRAWAL
    ANDREWS, WJ
    VASQUEZ, B
    NAGULESPARAN, M
    KLIMES, I
    FOLEY, J
    UNGER, R
    REAVEN, GM
    [J]. DIABETES, 1984, 33 (07) : 634 - 642
  • [2] [Anonymous], 2001, GUID DOC US IN VITR
  • [3] Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up
    Ärnlöv, J
    Lind, L
    Zethelius, B
    Andrén, B
    Hales, CN
    Vessby, B
    Lithell, H
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (04) : 720 - 724
  • [4] ASMAL AC, 1980, S AFR MED J, V57, P788
  • [5] DIABETIC CARDIOMYOPATHY - A UNIQUE ENTITY OR A COMPLICATION OF CORONARY-ARTERY DISEASE
    BELL, DSH
    [J]. DIABETES CARE, 1995, 18 (05) : 708 - 714
  • [6] RELATIONSHIPS BETWEEN INSULIN-SECRETION, INSULIN ACTION, AND FASTING PLASMA-GLUCOSE CONCENTRATION IN NONDIABETIC AND NONINSULIN-DEPENDENT DIABETIC SUBJECTS
    BOGARDUS, C
    LILLIOJA, S
    HOWARD, BV
    REAVEN, G
    MOTT, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) : 1238 - 1246
  • [7] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    [J]. LANCET, 2002, 359 (9311) : 995 - 1003
  • [8] Freeman DJ, 2001, CIRCULATION, V103, P357
  • [9] Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
  • [10] Gavin JR, 1997, DIABETES CARE, V20, P1183